Enabling Innovation Initiative (Ei2) Seminar Series 2022 kick-off seminar Friday, Sept 9, 2022, 2pm
Read more about the Ei2 Seminar Series here: https://medschool.vanderbilt.edu/ei2/
Friday, September 9, 2022, at 2:00 pm in the Light Hall 2nd floor auditorium (room TBA)
“So you want to be an entrepreneur . . .”
Chuck Haines, Ph.D., CEO IDBiologics
So you think you want to be an entrepreneur… I am an entrepreneur, an eternal optimist struggling every day against long odds. I am lucky enough to have my dream job! But I also have to do many things that I dread – it comes with the territory. I am constantly rejected, but the rare successes are truly meaningful. If this still sounds interesting, I’m happy to tell you more about my journey from academia to a biotech startup.
About IDBiologics
IDBiologics was founded in 2017 to discover and develop human monoclonal antibodies for the prevention, treatment, and cure of infectious diseases.
Our innovative fully human monoclonal antibody platform enables rapid discovery and optimization of broad and potent therapeutic molecules.
Using this proprietary platform, IDBiologics has accumulated unparalleled breadth in isolating antibodies for infectious diseases, with lead candidate molecules to diverse targets moving forward in development.
This lecture takes place in-person on Friday, September 9, 2022, at 2:00 pm in the Light Hall 2nd floor auditorium (room TBA).
Registration is required: Register Here!